International Journal of Bipolar Disorders

Papers
(The median citation count of International Journal of Bipolar Disorders is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Ethnic differences in efficacy of drug treatment in patients with an acute manic episode: an individual patient data meta-analysis of randomized placebo-controlled trials33
Psychological symptoms during and after Austrian first lockdown in individuals with bipolar disorder? A follow-up control-group investigation30
Lithium and its effects: does dose matter?28
Internet of things issues related to psychiatry26
Paediatric bipolar disorder: an age-old problem20
Combining predominant polarity and affective spectrum concepts in bipolar disorder: towards a novel theoretical and clinical perspective18
Perceived cognitive loss, symptomology, and psychological well-being with bipolar disorder14
Medical comorbidities in bipolar disorder (BIPCOM): clinical validation of risk factors and biomarkers to improve prevention and treatment. Study protocol14
Evaluating the quality, safety, and functionality of commonly used smartphone apps for bipolar disorder mood and sleep self-management14
Correction: Overview of lithium’s use: a nationwide survey14
Methylomic biomarkers of lithium response in bipolar disorder: a clinical utility study14
Key questions on the long term renal effects of lithium: a review of pertinent data13
The big five model in bipolar disorder: a latent profile analysis and its impact on longterm illness severity12
Aripiprazole once-monthly for the treatment of adult patients with earlier-stage bipolar I disorder: a post hoc analysis of data from a double-blind, placebo-controlled, 52-week randomized withdrawal 12
Search for surrogate markers to predict end stage kidney disease in long term lithium users12
The association between variability, intensity, and persistence of suicidal ideation and prospective suicidal behavior in the systematic treatment enhancement program for bipolar disorder (STEP-BD) st12
Estimated glomerular filtration rate in Korean patients exposed to long-term lithium maintenance therapy12
Dynamics of affect modulation in neurodevelopmental disorders (DynAMoND) – study design of a prospective cohort study11
Lipid oxidation in young patients with newly diagnosed bipolar disorder and their relatives11
Mitochondrial genetic variants associated with bipolar disorder and Schizophrenia in a Japanese population11
Association between childhood trauma, cognition, and psychosocial function in a large sample of partially or fully remitted patients with bipolar disorder and healthy participants11
Effectiveness of ultra-long-term lithium treatment: relevant factors and case series11
Psychological therapy for mood instability within bipolar spectrum disorder: a randomised, controlled feasibility trial of a dialectical behaviour therapy-informed approach (the ThrIVe-B programme)11
Characteristics of rapid cycling in 1261 bipolar disorder patients10
Efficacy and safety of adjunctive therapy to lamotrigine, lithium, or valproate monotherapy in bipolar depression: a systematic review and meta-analysis of randomized controlled trials10
Perceived loneliness and social support in bipolar disorder: relation to suicidal ideation and attempts10
Differential characteristics of bipolar I and II disorders: a retrospective, cross-sectional evaluation of clinical features, illness course, and response to treatment10
A systematic review of the biomarkers associated with cognition and mood state in bipolar disorder9
Clinicians’ preferences and attitudes towards the use of lithium in the maintenance treatment of bipolar disorders around the world: a survey from the ISBD Lithium task force9
Is cognitive behaviour therapy applicable to individuals diagnosed with bipolar depression or suboptimal mood stabilizer treatment: a secondary analysis of a large pragmatic effectiveness trial9
Twenty-four years of prescription patterns in bipolar disorder inpatients with vs without lithium: a pharmacoepidemiological analysis of 8,707 cases in German-speaking countries9
Lithium in the time of COVID: forever vigilant9
Lithium: current state of the art and future directions8
Stigma in people living with bipolar disorder and their families: a systematic review8
A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of lamotrigine in the maintenance treatment of Chinese adult patients with bipolar I disorder8
Two bipolar disorders or one? In reply to commentary by Malhi and Bell8
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder8
Long-term outcome of postpartum psychosis: a prospective clinical cohort study in 106 women7
Lithium-discontinuation-induced treatment refractoriness revisited7
Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study7
Early detection of bipolar disorders and treatment recommendations for help-seeking adolescents and young adults: Findings of the Early Detection and Intervention Center Dresden7
Characteristics of people with bipolar disorder I with and without auditory verbal hallucinations6
Association between a large change between the minimum and maximum monthly values of solar insolation and a history of suicide attempts in bipolar I disorder6
Lithium use in childhood and adolescence, peripartum, and old age: an umbrella review6
Valproic acid autoinduction: a case-based review6
Predicting the risk and timing of major mood disorder in offspring of bipolar parents: exploring the utility of a neural network approach6
Lithium induced hypercalcemia: an expert opinion and management algorithm6
The bipolar two-syndrome concept: questioning the shaping of a circular argument for subtyping a dimensional disorder6
Familial load of psychiatric disorders and overall functioning in patients newly diagnosed with bipolar disorder and their unaffected first-degree relatives5
Prevention of suicidal behavior with lithium treatment in patients with recurrent mood disorders5
The German research consortium for the study of bipolar disorder (BipoLife): a quality assurance protocol for MR neuroimaging data5
Neonatal admission after lithium use in pregnant women with bipolar disorders: a retrospective cohort study5
The relations between executive functions and occupational functioning in individuals with bipolar disorder: a scoping review5
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder4
Impact of modification to DSM-5 criterion A for hypomania/mania in newly diagnosed bipolar patients: findings from the prospective BIO study4
Toxoplasma gondii IgG serointensity and cognitive function in bipolar disorder4
Differential diagnosis of unipolar versus bipolar depression by GSK3 levels in peripheral blood: a pilot experimental study4
Patients’ adherence to smartphone apps in the management of bipolar disorder: a systematic review4
Environmental factors in offspring of parents with mood disorders and their role in parent–child transmission: findings from a 14-year prospective high-risk study4
Quality of life in persons at risk for bipolar disorder: a two year prospective-longitudinal observational cohort study (BipoLife)4
A call for improving lithium literacy among clinicians and patients4
Letter to the editor regarding the article, “Type of cycle, temperament and childhood trauma are associated with lithium response in patients with bipolar disorders”4
The interplay of daily affect and impulsivity measured by mobile surveys in bipolar disorder4
Psychedelics in the treatment of unipolar and bipolar depression4
Correction: Effectiveness of ultra-long-term lithium treatment: relevant factors and case series4
Using density of antecedent events and trajectory path analysis to investigate family-correlated patterns of onset of bipolar I disorder: a comparison of cohorts from Europe and USA4
Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice3
Omega-3 fatty acids in bipolar patients with a low omega-3 index and reduced heart rate variability: the “BIPO-3” trial3
Evaluating endophenotypes for bipolar disorder3
Correlations between multimodal neuroimaging and peripheral inflammation in different subtypes and mood states of bipolar disorder: a systematic review3
Late chronotype predicts more depressive symptoms in bipolar disorder over a 5 year follow-up period3
Bipolar disorders in Nigeria: a mixed-methods study of patients, family caregivers, clinicians, and the community members’ perspectives3
The research landscape of bipolar disorder in Germany: productive, but underfunded3
“Bad timing for illness relapse!” Mood symptoms, challenges and strategies for wellbeing in the first year postpartum among infant mothers with bipolar disorder: a mixed-methods study3
NRX-101 (D-cycloserine plus lurasidone) vs. lurasidone for the maintenance of initial stabilization after ketamine in patients with severe bipolar depression with acute suicidal ideation and behavior:3
Risk of childhood trauma exposure and severity of bipolar disorder in Colombia3
Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder3
Clinical research diagnostic criteria for bipolar illness (CRDC-BP): rationale and validity3
Emotion regulation in bipolar disorder type-I: multivariate analysis of fMRI data3
Anticipating manic and depressive transitions in patients with bipolar disorder using early warning signals3
A systematic review of interventions in the early course of bipolar disorder I or II: a report of the International Society for Bipolar Disorders Taskforce on early intervention3
Antidepressant efficacy of low-frequency repetitive transcranial magnetic stimulation in antidepressant-nonresponding bipolar depression: a single-blind randomized sham-controlled trial3
Structured physical exercise for bipolar depression: an open-label, proof-of concept study3
Is the 4-factor model of symptomology equivalent across bipolar disorder subtypes?3
0.037175893783569